FDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration is warning...
Read More
Otolaryngology
Manifestations of Vertigo Described in Pregnancy
FRIDAY, Nov. 18, 2022 (HealthDay News) — Pregnancy can bring about the onset of or...
Read More
High Prevalence of Youth Estimated at Greater Risk for Hearing Loss
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — The number of young people who may be at risk...
Read More
USPSTF: Evidence Inadequate for Recommending OSA Screening
TUESDAY, Nov. 15, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF)...
Read More
1999 to 2018 Saw Increase in Barriers to Timely Medical Care
FRIDAY, Oct. 28, 2022 (HealthDay News) — From 1999 to 2018, barriers to timely medical care...
Read More
FDA Warns of Amoxicillin Shortage
MONDAY, Oct. 31, 2022 (HealthDay News) — Supplies of amoxicillin oral solution are low, the...
Read More
Higher Work Hours Linked to Depressive Symptoms for Interns
THURSDAY, Oct. 27, 2022 (HealthDay News) — For interns, higher work hours are associated...
Read More
Female Med Students Publish Less, Despite Higher Number of Research Experiences
WEDNESDAY, Oct. 26, 2022 (HealthDay News) — Among medical school students, there are...
Read More
Inner Ear Structural Assignment Method May ID Meniere Disease
MONDAY, Oct. 24, 2022 (HealthDay News) — The Inner Ear Structural Assignment Method (IESAM)...
Read More
Considerable Medical Costs Associated With Recurrent Vertigo
THURSDAY, Oct. 20, 2022 (HealthDay News) — The three most common causes of recurrent vertigo...
Read More
#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
Click to read this study in JAMA Otolaryngology – Head & Neck...
Read More
#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
1. Pembrolizumab-alone or pembrolizumab-chemotherapy prolonged overall survival vs...
Read More
Physicians With Disabilities Experience More Mistreatment
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — Physicians with disabilities had a significantly...
Read More
Review: Results of Endolymphatic Sac Surgery Mixed in Meniere Disease
THURSDAY, Oct. 20, 2022 (HealthDay News) — Endolymphatic sac surgery appears to offer mixed...
Read More
Thirty-Seven Percent of Adults Used Telemedicine in 2021
THURSDAY, Oct. 13, 2022 (HealthDay News) — In 2021, 37.0 percent of adults used telemedicine...
Read More
#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma
Click to read this study in the Journal of Clinical Oncology.
Read More
Move to Zero-Emission Trucks Could Save 66,000 U.S. Lives
THURSDAY, Oct. 6, 2022 (HealthDay News) — Replacing diesel-powered trucks with electric...
Read More
Most Safety Signals Reported to FDA Lead to Regulatory Action
THURSDAY, Oct. 6, 2022 (HealthDay News) — Most potential safety signals identified from the...
Read More
Male Physicians Receive More and Higher Payments From Medical Companies
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Male physicians receive significantly higher...
Read More